Medical News Today -
9 Jan 2014 12:00
Intravenous/Sublingual Tissue-Penetrating Homing Peptide Enhances Activity of Other Pulmonary Drugs, According to New Research Published in The American Journal of Pathology.The development of new, more effective vasodilators to treat pulmonary arterial hypertension (PAH) has been hampered because of their systemic toxicity and adverse side effects.
Share this Article